Centralized Management for NJ Taxotere Lawsuits Requested

Introduction

Taxotere linked thousands of lawsuits were centralized in October 2016 under MDL No. 2740 (in re Taxotere (Docetaxel) Products Liability Litigation) before Judge Kurt D. Engelhardt in the Eastern District of Louisiana; four cases have been selected to be a part of the first series of bellwether trials to begin in September.

With the mounting number of similar claims in New Jersey, a request for a centralized management has been requested by hundreds of women who filed their cases in New Jersey alleging that Sanofi-Aventis, the makers of the chemotherapy drug, failed to adequately warn consumers about the risk of permanent hair loss from using the breast cancer drug Taxotere.

Comments

Walgreens Settles Federal Opioid Case for $300 Million

Categories: Opioids

Walgreens has agreed to pay $300 million to settle allegations by U.S. prosecutors that it unlawfully filled millions of invalid prescriptions for opioids and other controlled substances.

The U.S. Department of Justice announced on Monday…

Study: Opioid Use in Pregnancy May Shrink Newborn Brains

Categories: Opioids

New research from Children’s National Hospital in Washington, D.C., reveals that infants exposed to opioids in the womb have significantly smaller brain volumes than…

Suboxone Tooth Loss Lawsuits Reviewed at MDL Meeting

Categories: Opioids

The U.S. District Judge overseeing the federal Suboxone tooth decay multidistrict litigation (MDL) is scheduled to meet with attorneys tomorrow to assess the progress of pretrial proceedings and strategize on resolving over 11,000 product…

Centralized Management for NJ Taxotere Lawsuits Requested